Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.

Name: Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.
Author: Sanoff, Hanna K

Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer. — المؤلف: Sanoff, Hanna K — Nanomedicine : nanotechnology, biology, and medicine 20191203

المؤلف: Sanoff, Hanna K
النشر: Nanomedicine : nanotechnology, biology, and medicine 20191203
الوصف: 189-195 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Antineoplastic Combined Chemotherapy Protocols؛ Camptothecin؛ Capecitabine؛ Cohort Studies؛ Cyclodextrins